Microbix Biosystems Inc. (MBX:CA) Q2 2026 Earnings Call Transcript

Microbix Reports Results for H1 & Q2 2026

Microbix Schedules Release of Results for Q2 Fiscal 2026

Microbix Product Results Being Presented at 2026 PASCV

Microbix Engages with Diagnostics Industry Experts

Microbix Presenting at the 2026 Bloom Burton Conference

Microbix Exhibiting & Presenting at ESCMID Global 2026

Microbix Announces Annual Meeting Voting Results

Microbix Biosystems Inc. (MBX:CA) Shareholder/Analyst Call Transcript

Microbix Presents Reference-Material Innovations at EUROGIN

Microbix's Clot-Buster Drug Project Advances

Microbix Announces Issuance of Stock Options

Microbix Biosystems Inc. (MBX:CA) Q1 2026 Earnings Call Transcript

Microbix Reports Results for Q1 2026

Microbix Welcomes The College of American Pathologists as a Client For Supply of QAPs for PT/EQA Programs

Microbix Schedules Release of Results for Q1 Fiscal 2026

Microbix Presents Molecular Pathology Platform Results

Microbix Updates Investor Presentation on its Website

Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing

Microbix Biosystems Inc. (MBX:CA) Q4 2025 Earnings Call Transcript

Microbix Schedules Release of Results for Q4 Fiscal 2025

Microbix Launches New Products to Support H3N2 Flu Testing

Microbix & Seegene Mexico Collaborate to Improve Test Accuracy

Microbix Presenting at Muskoka Capital Event

Microbix Assisting EMQN with Second Genetic-Test EQA Program

Microbix Client Labquality Introduces Novel EQA Scheme at ESCV

Microbix Hosts Ontario Minister Stephen Crawford

Microbix Biosystems Inc. (MBXBF) Q2 2025 Earnings Call Transcript

Microbix Reports Results for Q3 Fiscal 2025

Microbix Launches QUANTDx™ Characterized Reference Materials

Microbix Exhibiting & Presenting at ADLM

Microbix & Bulgaria's NCIPD Execute Supply Agreement

Microbix Biosystems Inc. (MBXBF) Q2 2025 Earnings Call Transcript

Microbix Reports Results for Q2 Fiscal 2025

Microbix & Aurevia Introduce Novel EQA Scheme

Microbix Schedules Release of Results for Q2 Fiscal 2025

Microbix Presenting at the 2025 Bloom Burton Conference

Microbix Provides Business Updates

Microbix Announces Annual and Special Meeting Voting Results

Microbix Further Optimizes Capital Usage and Availability

Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific

Microbix Presenting at Investor Conference in B.C.

Microbix Biosystems Inc. (MBXBF) Q1 2025 Earnings Call Transcript

Microbix Reports Strong Revenues & Earnings for Q1 Fiscal 2025

Microbix Receives $2.4 Million from Exercise of Warrants

Microbix Biosystems Inc. (MBXBF) Q4 2024 Earnings Call Transcript

Microbix Reports Record Product Sales for Q4 and Fiscal 2024

Microbix Schedules Release of Results for Q4 Fiscal 2024

Microbix Assisting EMQN with Novel Genetic-Test EQA Program

Microbix Announces Initiation of Normal Course Issuer Bid